Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presentation, and it may therefore be challenging to diagnose. Specialized memory clinics vary in the type of patients seen, diagnostic procedures applied, and the pharmacological treatment given. The aim of this study was to investigate quality-of-care indicators in subjects with EOD from 3 tertiary memory clinics in 3 European countries.Methods: We included 1325 newly diagnosed EOD patients, ages 65 years or younger, between January 1, 2007 and December 31, 2013, from the Danish Dementia Registry (Rigshospitalet, Copenhagen), the Swedish Dementia Registry ("SveDem", Karolinska University Hospital, Stockholm), and the Amsterdam Dementia Cohort (VU U...
Article abstract—Objective: Calculation of incidence of dementia and AD, including cases in the earl...
Z Chemali1–3, S Schamber2, EC Tarbi2, D Acar1,2, M Avila-Urizar21Harvard Medical School, 2...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...
Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presenta...
Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presenta...
Dementia is more common in older age but a number of people develop symptoms at a younger age and ar...
Malaltia d'Alzheimer; Demència; EpidemiologiaEnfermedad de Alzheimer; Demencia; EpidemiologíaAlzheim...
Early-onset dementia (EOD, <65 years at onset) is a relatively common and frequently misdiagnosed co...
OBJECTIVES: To explore the extent of variation in the detection of dementia in primary care across E...
Objectives: To explore the extent of variation in the detection of dementia in primary care across E...
Item does not contain fulltextBACKGROUND: Timely recognition and diagnosis of dementia is the pre-co...
Background Timely recognition and diagnosis of dementia is the pre-condition for improving dementia ...
Contains fulltext : 46624.pdf (publisher's version ) (Closed access)BACKGROUND: Ti...
Background: The Swedish Dementia Registry (SveDem) was developed with the aim to improve the quality...
OBJECTIVES: To examine current UK practice in diagnosis of patients under 65 with young onset dement...
Article abstract—Objective: Calculation of incidence of dementia and AD, including cases in the earl...
Z Chemali1&ndash;3, S Schamber2, EC Tarbi2, D Acar1,2, M Avila-Urizar21Harvard Medical School, 2...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...
Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presenta...
Background: Early-onset dementia (EOD) is a rare condition, with an often atypical clinical presenta...
Dementia is more common in older age but a number of people develop symptoms at a younger age and ar...
Malaltia d'Alzheimer; Demència; EpidemiologiaEnfermedad de Alzheimer; Demencia; EpidemiologíaAlzheim...
Early-onset dementia (EOD, <65 years at onset) is a relatively common and frequently misdiagnosed co...
OBJECTIVES: To explore the extent of variation in the detection of dementia in primary care across E...
Objectives: To explore the extent of variation in the detection of dementia in primary care across E...
Item does not contain fulltextBACKGROUND: Timely recognition and diagnosis of dementia is the pre-co...
Background Timely recognition and diagnosis of dementia is the pre-condition for improving dementia ...
Contains fulltext : 46624.pdf (publisher's version ) (Closed access)BACKGROUND: Ti...
Background: The Swedish Dementia Registry (SveDem) was developed with the aim to improve the quality...
OBJECTIVES: To examine current UK practice in diagnosis of patients under 65 with young onset dement...
Article abstract—Objective: Calculation of incidence of dementia and AD, including cases in the earl...
Z Chemali1&ndash;3, S Schamber2, EC Tarbi2, D Acar1,2, M Avila-Urizar21Harvard Medical School, 2...
Purpose: Real-world studies to describe the use of first, second and third line therapies for the ma...